In this episode, we have the privilege of hosting the amazing Dr. Charles Keller, Scientific Director at the Children's Cancer Therapy Development Institute. The CCTDI is a 501C3 non-profit biotech that tries to both understand how cancers work, but also test and evaluate thoroughly the drugs that might hit a particular target to stop cancer from working. Dr. Charles shares how his team is helping facilitate the development of medication that works while also de-risking investment in the pharma space. He talks about the preclinical gap and shares anecdotal, challenges, setbacks, and more. Dr. Charles and his team are doing a wonderful job helping children with cancer. Learn more about CCTDI and how you can help in this episode.
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket